The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

PRLD Insider Trading (Prelude Therapeutics)

Insider Ownership Percentage: 76.47%
Insider Buying (Last 12 Months): $90,780.00
Insider Selling (Last 12 Months): $2,517,521.10

Prelude Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Prelude Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Prelude Therapeutics Share Price & Price History

Current Price: $8.67
Price Change: Price Increase of +0.36 (4.33%)
As of 08/12/2022 01:00 AM ET

This chart shows the closing price history over time for PRLD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

Prelude Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/1/2022Laurent ChardonnetCFOBuy10,000$4.23$42,300.0024,500View SEC Filing Icon  
12/13/2021Andrew CombsEVPBuy4,000$12.12$48,480.00View SEC Filing Icon  
11/16/2021Deborah MorosiniEVPSell28,751$15.88$456,565.88View SEC Filing Icon  
10/5/2021David J. MauroInsiderSell15,000$30.96$464,400.00View SEC Filing Icon  
9/7/2021David J. MauroInsiderSell15,000$36.69$550,350.00View SEC Filing Icon  
9/2/2021Christopher PierceEVPSell17,000$41.68$708,560.0020,750View SEC Filing Icon  
8/26/2021Peggy ScherleInsiderSell1,700$35.19$59,823.00View SEC Filing Icon  
8/25/2021Brian PiperCFOSell8,333$33.34$277,822.228,333View SEC Filing Icon  
8/5/2021David J. MauroInsiderSell15,000$31.09$466,350.00View SEC Filing Icon  
7/27/2021Peggy ScherleInsiderSell20,000$35.47$709,400.00View SEC Filing Icon  
7/6/2021David J. MauroInsiderSell15,000$27.47$412,050.0015,000View SEC Filing Icon  
6/7/2021David J. MauroInsiderSell15,000$32.44$486,600.0015,000View SEC Filing Icon  
5/25/2021Brian PiperCFOSell8,333$34.27$285,571.918,333View SEC Filing Icon  
5/7/2021Peggy ScherleInsiderSell10,000$40.82$408,200.00View SEC Filing Icon  
5/5/2021David J. MauroInsiderSell15,000$40.14$602,100.0015,000View SEC Filing Icon  
4/29/2021Christopher PierceEVPSell3,295$40.29$132,755.553,667View SEC Filing Icon  
4/19/2021David J. MauroInsiderSell25,000$30.89$772,250.0025,000View SEC Filing Icon  
4/7/2021Christopher PierceEVPSell828$40.08$33,186.244,578View SEC Filing Icon  
4/7/2021Peggy ScherleinsiderSell15,370$39.31$604,194.7015,383View SEC Filing Icon  
See Full Table
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

SEC Filings (Institutional Ownership Changes) for Prelude Therapeutics (NASDAQ:PRLD)

73.80% of Prelude Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PRLD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Prelude Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2022Massachusetts Financial Services Co. MA478,525$2.50M0.0%-0.7%1.000%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC160,486$0.84M0.0%+300.2%0.336%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp21,167$0.11M0.0%-79.2%0.044%Search for SEC Filing on Google Icon
8/12/2022Virtus ETF Advisers LLC24,005$0.13M0.0%+84.0%0.050%Search for SEC Filing on Google Icon
8/12/2022FMR LLC4,302,969$22.46M0.0%-19.9%8.996%Search for SEC Filing on Google Icon
7/19/2022Commonwealth Equity Services LLC16,617$86K0.0%-18.8%0.035%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE135,237$0.93M0.0%+72.3%0.284%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.24,090$0.17M0.0%-78.7%0.051%Search for SEC Filing on Google Icon
5/16/2022PDT Partners LLC71,822$0.50M0.0%+100.0%0.151%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC40,100$0.28M0.0%-68.5%0.084%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp101,906$0.70M0.0%-4.9%0.214%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.75,930$0.52M0.0%-10.8%0.159%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.800,498$5.52M0.0%+3.8%1.681%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.1,051,960$7.26M0.0%+17.3%2.209%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers10,050$69K0.0%N/A0.021%Search for SEC Filing on Google Icon
5/11/2022Massachusetts Financial Services Co. MA482,119$3.33M0.0%+2.8%1.012%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP23,201$0.16M0.0%N/A0.049%Search for SEC Filing on Google Icon
5/6/2022IndexIQ Advisors LLC56,750$0.39M0.0%N/A0.119%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund4,992$34K0.0%-45.1%0.010%Search for SEC Filing on Google Icon
5/4/2022Commonwealth Equity Services LLC20,467$0.14M0.0%-10.4%0.043%Search for SEC Filing on Google Icon
3/3/2022Walleye Capital LLC41,954$0.52M0.0%N/A0.089%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC35,907$0.45M0.0%N/A0.076%Search for SEC Filing on Google Icon
2/14/2022Virtus ETF Advisers LLC13,815$0.17M0.1%+119.6%0.029%Search for SEC Filing on Google Icon
2/14/2022Point72 Hong Kong Ltd3,872$48K0.0%+141.7%0.008%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc8,080$0.10M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/11/2022Parkwood LLC12,667$0.16M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd23,384$0.29M0.0%N/A0.050%Search for SEC Filing on Google Icon
2/10/2022Massachusetts Financial Services Co. MA468,797$5.84M0.0%-0.7%0.993%Search for SEC Filing on Google Icon
2/8/2022Swiss National Bank27,500$0.34M0.0%+34.1%0.058%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd23,384$0.29M0.0%N/A0.050%Search for SEC Filing on Google Icon
1/31/2022Commonwealth Equity Services LLC22,832$0.28M0.0%+69.4%0.048%Search for SEC Filing on Google Icon
12/14/2021UBS Asset Management Americas Inc.1,483,319$46.35M0.0%+15.2%3.142%Search for SEC Filing on Google Icon
11/15/2021Point72 Hong Kong Ltd1,602$50K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/15/2021Cubist Systematic Strategies LLC21,755$0.68M0.0%+26.5%0.046%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System13,524$0.42M0.0%-9.5%0.029%Search for SEC Filing on Google Icon
11/15/2021Rock Springs Capital Management LP362,359$11.32M0.2%-5.2%0.769%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley756,787$23.65M0.0%+472.6%1.607%Search for SEC Filing on Google Icon
11/12/2021Credit Suisse AG6,950$0.22M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC249,172$7.79M0.0%+11.6%0.529%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.8,659$0.27M0.0%-53.5%0.018%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.24,268$0.76M0.0%-67.9%0.052%Search for SEC Filing on Google Icon
11/10/2021Rafferty Asset Management LLC36,936$1.15M0.0%-25.8%0.078%Search for SEC Filing on Google Icon
11/10/2021Alliancebernstein L.P.13,700$0.43M0.0%-23.5%0.029%Search for SEC Filing on Google Icon
11/10/2021Massachusetts Financial Services Co. MA472,246$14.76M0.0%+25.9%1.003%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.725,962$22.69M0.0%+3.3%1.542%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG6,537$0.21M0.0%-82.4%0.014%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC8,691$0.27M0.0%N/A0.018%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC13,482$0.42M0.0%+23.4%0.029%Search for SEC Filing on Google Icon
8/17/2021Logos Global Management LP400,000$11.45M1.0%N/A0.852%Search for SEC Filing on Google Icon
8/17/2021Metropolitan Life Insurance Co NY3,194$91K0.0%+106,366.7%0.007%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD400,802$11.48M0.0%-5.2%0.854%Search for SEC Filing on Google Icon
8/16/2021UBS Asset Management Americas Inc.1,287,735$36.87M0.0%+100.3%2.742%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC17,197$0.49M0.0%+168.9%0.037%Search for SEC Filing on Google Icon
8/16/2021Hhlr Advisors LTD.583,333$16.70M0.2%-6.9%1.242%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley132,165$3.78M0.0%+449.0%0.281%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.72,623$2.08M0.0%-2.7%0.155%Search for SEC Filing on Google Icon
8/16/2021State Street Corp1,052,216$30.13M0.0%+20.5%2.241%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.18,617$0.53M0.0%-57.2%0.040%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp118,677$3.40M0.0%+2.8%0.253%Search for SEC Filing on Google Icon
8/13/2021Jump Financial LLC13,700$0.39M0.0%+117.5%0.029%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC223,252$6.39M0.0%+12.1%0.475%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.1,126,047$32.24M0.0%+29.8%2.398%Search for SEC Filing on Google Icon
8/13/2021Massachusetts Financial Services Co. MA375,166$10.74M0.0%+33.4%0.799%Search for SEC Filing on Google Icon
8/13/2021FMR LLC6,552,499$187.60M0.0%+4.8%13.954%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.6,889$0.20M0.0%+9.4%0.015%Search for SEC Filing on Google Icon
8/11/2021Commonwealth Equity Services LLC10,927$0.31M0.0%N/A0.023%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp30,254$0.87M0.0%-2.5%0.064%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.702,842$20.12M0.0%+3.1%1.497%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG37,133$1.06M0.0%+1.5%0.079%Search for SEC Filing on Google Icon
8/11/2021Susquehanna International Group LLP17,153$0.49M0.0%N/A0.037%Search for SEC Filing on Google Icon
8/10/2021Virtus ETF Advisers LLC6,622$0.19M0.1%N/A0.014%Search for SEC Filing on Google Icon
8/10/2021Citigroup Inc.75,623$2.17M0.0%+24.8%0.161%Search for SEC Filing on Google Icon
8/10/2021Rafferty Asset Management LLC49,780$1.43M0.0%+2.7%0.106%Search for SEC Filing on Google Icon
8/6/2021Swiss National Bank20,500$0.59M0.0%N/A0.044%Search for SEC Filing on Google Icon
8/5/2021Rhumbline Advisers8,775$0.25M0.0%-9.2%0.019%Search for SEC Filing on Google Icon
7/30/2021Alliancebernstein L.P.17,900$0.51M0.0%+72.1%0.038%Search for SEC Filing on Google Icon
5/19/2021Hillhouse Capital Advisors LTD.626,502$27.15M0.3%-16.5%1.765%Search for SEC Filing on Google Icon
5/18/2021Baker BROS. Advisors LP10,123,824$438.67M1.9%+0.1%28.522%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC13,503$0.59M0.0%N/A0.038%Search for SEC Filing on Google Icon
5/18/2021D. E. Shaw & Co. Inc.12,546$0.54M0.0%N/A0.035%Search for SEC Filing on Google Icon
5/18/2021State of Wisconsin Investment Board13,300$0.58M0.0%N/A0.037%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley24,074$1.04M0.0%-11.3%0.068%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC6,395$0.28M0.0%N/A0.018%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC19,496$0.85M0.0%N/A0.055%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System14,947$0.65M0.0%+7.6%0.042%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada3,449$0.15M0.0%+21.8%0.010%Search for SEC Filing on Google Icon
5/17/2021Rock Springs Capital Management LP378,195$16.39M0.4%+4.9%1.065%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD422,991$18.33M0.0%+9.1%1.192%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC37,346$1.62M0.0%+7.6%0.105%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.43,509$1.89M0.0%N/A0.123%Search for SEC Filing on Google Icon
5/14/2021TD Asset Management Inc.28,440$1.23M0.0%+26.3%0.080%Search for SEC Filing on Google Icon
5/14/2021UBS Asset Management Americas Inc.642,979$27.86M0.0%+24.6%1.811%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.60,597$2.63M0.0%+3,400.7%0.171%Search for SEC Filing on Google Icon
5/13/2021Massachusetts Financial Services Co. MA281,164$12.18M0.0%-1.1%0.792%Search for SEC Filing on Google Icon
5/13/2021Federated Hermes Inc.336,100$14.56M0.0%+124.1%0.947%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp115,499$5.01M0.0%+0.4%0.325%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC199,191$8.63M0.0%+3.9%0.561%Search for SEC Filing on Google Icon
5/12/2021Ensign Peak Advisors Inc17,498$0.76M0.0%N/A0.049%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.6,295$0.27M0.0%-74.3%0.018%Search for SEC Filing on Google Icon
5/12/2021E Fund Management Co. Ltd.2,016$87K0.0%N/A0.006%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Prelude Therapeutics logo
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; PRT3645, a brain penetrant molecule that potently and selectively targets CDK4/6; and PRT-K4 that is in preclinical stage for solid tumors. The company was incorporated in 2016 and is headquartered in Wilmington, Delaware.
Read More on Prelude Therapeutics

Today's Range

Now: $8.67
Low: $8.00
High: $8.75

50 Day Range

MA: $5.48
Low: $4.32
High: $8.67

52 Week Range

Now: $8.67
Low: $3.87
High: $43.55

Volume

65,608 shs

Average Volume

113,006 shs

Market Capitalization

$414.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.75

Who are the company insiders with the largest holdings of Prelude Therapeutics?

Prelude Therapeutics' top insider shareholders include:
  1. David J Mauro (Insider)
  2. Laurent Chardonnet (CFO)
  3. Christopher Pierce (EVP)
  4. Peggy Scherle (Insider)
  5. David J Mauro (Insider)
  6. Brian Piper (CFO)
  7. Andrew Combs (EVP)
  8. David J Mauro (Director)
  9. Deborah Morosini (EVP)
Learn More about top insider investors at Prelude Therapeutics.

Who are the major institutional investors of Prelude Therapeutics?

Prelude Therapeutics' top institutional investors include:
  1. FMR LLC — 9.00%
  2. Massachusetts Financial Services Co. MA — 1.00%
  3. Renaissance Technologies LLC — 0.34%
  4. Virtus ETF Advisers LLC — 0.05%
  5. Northern Trust Corp — 0.04%
  6. Commonwealth Equity Services LLC — 0.03%
Learn More about top institutional investors of Prelude Therapeutics stock.

Which major investors are selling Prelude Therapeutics stock?

During the last quarter, PRLD stock was sold by these institutional investors:
  1. FMR LLC
  2. Northern Trust Corp
  3. Commonwealth Equity Services LLC
  4. Massachusetts Financial Services Co. MA
During the last year, company insiders that have sold Prelude Therapeutics company stock include:
  1. David J Mauro (Insider)
  2. Laurent Chardonnet (CFO)
  3. Christopher Pierce (EVP)
  4. Peggy Scherle (Insider)
  5. David J Mauro (Insider)
Learn More investors selling Prelude Therapeutics stock.

Which major investors are buying Prelude Therapeutics stock?

In the last quarter, PRLD stock was purchased by institutional investors including:
  1. Renaissance Technologies LLC
  2. Virtus ETF Advisers LLC
During the last year, these company insiders have bought Prelude Therapeutics stock:
  1. David J Mauro (Insider)
  2. Laurent Chardonnet (CFO)
  3. Christopher Pierce (EVP)
Learn More investors buying Prelude Therapeutics stock.
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.